Authors: Rusnak, DW Affleck, K Cockerill, SG Stubberfield, C Harris, R Page, M Smith, KJ Guntrip, SB Carter, MC Shaw, RJ Jowett, A Stables, J Topley, P Wood, ER Brignola, PS Kadwell, SH Reep, BR Mullin, RJ Alligood, KJ Keith, BR Crosby, RM Murray, DM Knight, WB Gilmer, TM Lackey, K

Citation: Dw. Rusnak et al., The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer, CANCER RES, 61(19), 2001, pp. 7196-7203

Authors: Wolfe, LA Mullin, RJ Laethem, R Blumenkopf, TA Cory, M Miller, JF Keith, BR Humphreys, J Smith, GK

Citation: La. Wolfe et al., Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: In vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843, BIOCONJ CHE, 10(1), 1999, pp. 38-48